Guaifenesin · DIN 00026794 · 20 mg/mL · oral liquid
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1998-04-01 — choose a marketed DIN from the same-category list.Discontinued April 1, 1998 · checked November 18, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1998-04-01 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 1998-04-01 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Guaifenesin · DIN 00026794
Manufacturer: Rougier Pharma, Division of Ratiopharm Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 1998-04-01 · brand BALMINIL EXPECTORANT LIQ 100MG/5ML · ATC R05CA03 GUAIFENESIN · form Liquid · route Oral · ingredients GUAIFENESIN 100 MG/5ML · company Rougier pharma division of ratiopharm inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordGuaifenesin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00026794)
Source record
DIN 00026794: Guaifenesin
Raw flags: notABenefit=Y, sec3=Y
Item: 480800003; group id 573; item number 1525; lccId None; manufacturer id ROG
Source form: O/L; strength: 20mg/mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00026794
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3423
Interchangeable products
Guaifenesin Sugar Free · DIN 00990930 · not recorded
Robitussin · DIN 00026468 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00026794
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 1, 1998 — choose a marketed DIN from the same-category list.